Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc

Human GLP-1 (glucagon-like peptide-1) can produce a remarkable improvement in glycemic control in patients with type 2 diabetes. However, its clinical benefits are limited by its short half-life, which is less than 2 min because of its small size and rapid enzymatic inactivation by dipeptidyl peptid...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi, Chen, Fang, Wan, Deyou, Liu, Yunhui, Yang, Li, Feng, Hongru, Cui, Xinling, Gao, Xin, Song, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883776/
https://www.ncbi.nlm.nih.gov/pubmed/27232339
http://dx.doi.org/10.1371/journal.pone.0156449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883776/
https://www.ncbi.nlm.nih.gov/pubmed/27232339
http://dx.doi.org/10.1371/journal.pone.0156449

Ejemplares similares